T2 Biosystems Inc.
Find Ratings ReportsT2 BIOSYSTEMS INC's gross profit margin for the third quarter of its fiscal year 2023 has significantly decreased when compared to the same period a year ago. Even though sales decreased, the net income has increased. T2 BIOSYSTEMS INC has very weak liquidity. Currently, the Quick Ratio is 0.46 which clearly shows a lack of ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.
At the same time, stockholders' equity ("net worth") has greatly increased by 38.61% from the same quarter last year. The key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
Income Statement | Q3 FY23 | Q3 FY22 |
---|---|---|
Net Sales ($mil) | 1.47 | 3.68 |
EBITDA ($mil) | -10.83 | -15.54 |
EBIT ($mil) | -11.1 | -15.8 |
Net Income ($mil) | -15.43 | -17.38 |
Balance Sheet | Q3 FY23 | Q3 FY22 |
---|---|---|
Cash & Equiv. ($mil) | 24.32 | 20.37 |
Total Assets ($mil) | 43.28 | 43.95 |
Total Debt ($mil) | 49.48 | 59.05 |
Equity ($mil) | -19.24 | -31.34 |
Profitability | Q3 FY23 | Q3 FY22 |
---|---|---|
Gross Profit Margin | -148.85 | -58.42 |
EBITDA Margin | -736.0 | -422.62 |
Operating Margin | -753.8 | -429.7 |
Sales Turnover | 0.25 | 0.54 |
Return on Assets | -115.14 | -145.72 |
Return on Equity | 0.0 | 0.0 |
Debt | Q3 FY23 | Q3 FY22 |
---|---|---|
Current Ratio | 0.59 | 2.64 |
Debt/Capital | 1.64 | 2.13 |
Interest Expense | 1.12 | 1.56 |
Interest Coverage | -9.92 | -10.13 |
Share Data | Q3 FY23 | Q3 FY22 |
---|---|---|
Shares outstanding (mil) | 3.92 | 0.07 |
Div / share | 0.0 | 0.0 |
EPS | -3.0 | -300.0 |
Book value / share | -4.91 | -444.46 |
Institutional Own % | n/a | n/a |
Avg Daily Volume | 346862.0 | 2.9158308E7 |
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. Along with this, the price-to-book ratio is also meaningless due to a negative book value for the company, making any comparisons useless. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount.
Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TTOO NM | Peers 85.83 | TTOO NM | Peers 38.76 | |||||||||||||||||||||
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings. TTOO's P/E is negative making this valuation measure meaningless. |
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. TTOO's P/CF is negative making the measure meaningless. |
|||||||||||||||||||||||
Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
TTOO NM | Peers 18.08 | TTOO NA | Peers 1.16 | |||||||||||||||||||||
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings. TTOO's ratio is negative making this valuation measure meaningless. |
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. Ratio not available. |
|||||||||||||||||||||||
Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
TTOO NM | Peers 19.07 | TTOO 83.10 | Peers 12.58 | |||||||||||||||||||||
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. TTOO's P/B is negative making this valuation measure meaningless. |
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. TTOO is expected to have an earnings growth rate that significantly exceeds its peers. |
|||||||||||||||||||||||
Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
TTOO 1.43 | Peers 84.44 | TTOO -53.80 | Peers 42.35 | |||||||||||||||||||||
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. TTOO is trading at a significant discount to its subsector on this measurement. |
Lower. A sales growth rate that trails the subsector implies that a company is losing market share. TTOO significantly trails its peers on the basis of sales growth. |
|||||||||||||||||||||||